PlainIndex

ETF comparison

IEMG vs PXF

International Emerging vs International Developed.

iShares Core MSCI Emerging Markets ETF · Invesco RAFI Developed Markets ex-U.S. ETF

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of IEMG and PXF would leave roughly 0.0% of each dollar exposed to the same underlying securities.

IEMG only 0.0% Shared 0.0% PXF only 0.0%
In IEMG only
0 positions
Shared
0 positions
In PXF only
0 positions

Holdings data for IEMG covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for PXF covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

IEMG

iShares Core MSCI Emerging Markets ETF

iShares · International Emerging

89 composite / 100
Expense ratio
0.090%
Net assets
$151.17B
TTM yield
2.37%
Top-10 conc.
—
PXF

Invesco RAFI Developed Markets ex-U.S. ETF

Invesco · International Developed

66 composite / 100
Expense ratio
0.43%
Net assets
$2.79B
TTM yield
3.25%
Top-10 conc.
—

Sub-score comparison

91
Cost
57
72
Tax efficiency
71
100
Liquidity
76
N/A
Concentration
N/A
—
Tracking quality
—
IEMG sub-score PXF

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

IEMG is 34 bps cheaper than PXF. On a $100,000 position that's about $340/yr more in fees for PXF.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in IEMG

0 total

Every IEMG position is also held by PXF.

Only in PXF

0 total

Every PXF position is also held by IEMG.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.